JPRN-jRCT2080222145未知3 期
KD-357 Phase III Study
适应症
试验速览
- 阶段
- 3 期
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 64age old（—）
- 性别
- All
入选标准
- •(1)Subjects who are healthy Japanese between 20 and 65 inclusive at the time of obtaining informed consent.
- •(2)Subjects who are able to give written informed consent.
排除标准
- 未提供
研究者
相似试验
未知
2 期
KD-357 Phase II/III Studypreexposure prophylaxis against rabiesJPRN-jRCT2080222295The Chemo-Sero-Therapeutic Research Institute30
未知
2 期
KD-370 Phase II study.The prevention of pertussis, diphtheria, tetanus, poliomyelitis, and infection caused by Haemophilus influenzae type b.JPRN-jRCT2080222866The Chemo-Sero-Therapeutic Research Institute
未知
3 期
TK-641 Phase 3 StudyJPRN-jRCT2080221351TEIKOKU SEIYAKU CO., LTD.
已完成
1 期
K-755 Phase 1 studyhealthy malesJPRN-jRCT2080224071Kowa Co., Ltd.78
进行中（未招募）
3 期
A phase III study for the evaluation of the immunogenicity and reactogenicity of GSK Biologicals' Quadrivalent Split Virion Influenza Vaccine Fluarix Tetra (2015 season Southern Hemisphere) in adults 18 years of age and aboveFluC02.782.620.365RBR-4bfx9cGlaxoSmithKline Biologicals